Clinical Trials in Boston

Showing 7561-7580 of 13,548 trials

WITHDRAWN< 1 mile

Microbiome Composition and Biomarker Discovery in Refractory Pediatric Epilepsy

NCT04311242

Research study to look for bio markers in epilepsy patients on ketogenic diet

Epilepsy

Senda BiosciencesStarted Apr 2020

Boston, Massachusetts, United States

TERMINATEDPhase 2< 1 mile

An Open-label Safety Study of Lusutrombopag (S-888711) in Adults With Chronic Immune Thrombocytopenia (ITP)

NCT01129024

The primary objective of this study was to assess the long-term safety of lusutrombopag in the treatment of adults with relapsed persistent or chronic ITP with or without prior splenectomy.

Immune Thrombocytopenia

Shionogi19 participantsStarted Apr 2010

Anaheim, California, United States • Los Angeles, California, United States • Washington D.C., District of Columbia, United States +16 more locations

COMPLETEDPhase 1< 1 mile

A Personal Cancer Vaccine (NEO-PV-01) With Pembrolizumab and Chemotherapy for Patients With Lung Cancer

NCT03380871

The purpose of this study is to find out if treatment with NEO-PV-01 in combination with pembrolizumab and chemotherapy (pembrolizumab/chemotherapy) is safe and useful for patients with lung cancer. The study also will assess if the NEO-PV-01 vaccine, when given together with pembrolizumab and chemotherapy, can improve your response compared with pembrolizumab and chemotherapy treatment alone. All eligible patients will receive NEO-PV-01 + Adjuvant, pembrolizumab and chemotherapy while on this trial.

Carcinoma, Non-Small-Cell LungLung CancerNonsquamous Nonsmall Cell Neoplasm of Lung

BioNTech US Inc.38 participantsStarted May 2018

Santa Monica, California, United States • Boston, Massachusetts, United States • Boston, Massachusetts, United States +2 more locations

Microbiome Composition and Biomarker Discovery in Refractory Pediatric Epilepsy

An Open-label Safety Study of Lusutrombopag (S-888711) in Adults With Chronic Immune Thrombocytopenia (ITP)

A Personal Cancer Vaccine (NEO-PV-01) With Pembrolizumab and Chemotherapy for Patients With Lung Cancer

Find Trials by Condition in Boston

NAPLS Omega-3 Fatty Acid Versus Placebo Study

A Personal Cancer Vaccine (NEO-PV-01) w/ Nivolumab for Patients With Melanoma, Lung Cancer or Bladder Cancer

Comparative Effectiveness of Two Tobacco Cessation Interventions for Employees of Partners HealthCare, Inc.

Cognitive-Behavioral Therapy for Avoidant/Restrictive Food Intake Disorder: A Treatment Development and Pilot Study

Screening for Atrial Fibrillation Among Older Patients in Primary Care Clinics

Kidney Information Network for Disease Research and Education

Stress Management and Resiliency Training for Physicians

Study Comparing Rovalpituzumab Tesirine Versus Topotecan in Subjects With Advanced or Metastatic Small Cell Lung Cancer With High Levels of Delta-like Protein 3 (DLL3) and Who Have First Disease Progression During or Following Front-line Platinum-based Chemotherapy (TAHOE)

Safety of FMT: OpenBiome Outcomes and Longitudinal Follow-up (STOOL) for Recurrent Clostridium Difficile Infection

Reducing Disparities in the Treatment of Hypertension Using the OWL mHealth Tool

Defining the PrEP Care Continuum Among Recently Incarcerated Men at High-Risk for HIV Infection

Working Memory in Overweight Children With and Without Loss of Control Eating

Emotion Regulation and Binge Eating in Youth With Obesity

Project CORE: Disseminating Eating Disorders Treatment

Trial to Evaluate the Safety and Immunogenicity of a 20-Valent Pneumococcal Vaccine in Adults 65 Years of Age or Older With Prior Pneumococcal Vaccination

Clinical Trial of BI 425809 Effect on Cognition and Functional Capacity in Schizophrenia

Atorvastatin Three Year Pediatric Study